20221121_lab meeting_怡君 | 賴亮全實驗室

索引

00:00 1.
index 1
01:28 2.
CircRNA-SORE was overexpressed in sorafenib-resistant HCC cells
05:10 3.
CircRNA-SORE was overexpressed in sorafenib-resistant HCC cells
05:18 4.
CircRNA-SORE was overexpressed in sorafenib-resistant HCC cells
07:09 5.
CircRNA-SORE was overexpressed in sorafenib-resistant HCC cells
11:04 6.
CircRNA-SORE was critical for maintaining sorafenib resistance
11:37 7.
CircRNA-SORE was critical for maintaining sorafenib resistance
14:21 8.
CircRNA-SORE was critical for maintaining sorafenib resistance
16:45 9.
CircRNA-SORE was critical for maintaining sorafenib resistance
18:07 10.
CircRNA-SORE functioned by binding to YBX1 protein
18:12 11.
CircRNA-SORE was critical for maintaining sorafenib resistance
18:24 12.
CircRNA-SORE functioned by binding to YBX1 protein
23:17 13.
CircRNA-SORE functioned by binding to YBX1 protein
27:53 14.
CircRNA-SORE functioned by binding to YBX1 protein
30:39 15.
CircRNA-SORE functioned by binding to YBX1 protein
32:43 16.
CircRNA-SORE functioned by binding to YBX1 protein
33:15 17.
CircRNA-SORE functioned by binding to YBX1 protein
33:19 18.
CircRNA-SORE functioned by binding to YBX1 protein
33:56 19.
Patients with lower circRNA-SORE or YBX1 expression were associated with better recurrence-free survival
42:44 20.
CircRNA-SORE stabilized YBX1 by preventing its PRP19-mediated degradation
47:08 21.
CircRNA-SORE stabilized YBX1 by preventing its PRP19-mediated degradation
47:58 22.
CircRNA-SORE stabilized YBX1 by preventing its PRP19-mediated degradation
50:41 23.
CircRNA-SORE stabilized YBX1 by preventing its PRP19-mediated degradation
51:56 24.
CircRNA-SORE stabilized YBX1 by preventing its PRP19-mediated degradation
54:44 25.
CircRNA-SORE transmited sorafenib resistance by exosomes
59:13 26.
CircRNA-SORE transmited sorafenib resistance by exosomes
1:05:11 27.
Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
1:05:26 28.
CircRNA-SORE transmited sorafenib resistance by exosomes
1:05:28 29.
** after 20221121.pptx
1:05:48 30.
CircRNA-SORE transmited sorafenib resistance by exosomes
1:06:19 31.
Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
1:06:21 32.
** after 20221121.pptx
1:06:25 33.
Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
1:08:31 34.
Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
1:08:46 35.
Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
1:09:22 36.
Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
1:09:30 37.
Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
1:09:33 38.
Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
1:09:39 39.
Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
1:12:00 40.
Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
1:12:10 41.
Conclusion
1:16:53 42.
** after 20221121.pptx

筆記 (0)

未登入或權限不足!

討論

00:00 1.
index 1
01:28 2.
CircRNA-SORE was overexpressed in sorafenib-resistant HCC cells
05:10 3.
CircRNA-SORE was overexpressed in sorafenib-resistant HCC cells
05:18 4.
CircRNA-SORE was overexpressed in sorafenib-resistant HCC cells
07:09 5.
CircRNA-SORE was overexpressed in sorafenib-resistant HCC cells
11:04 6.
CircRNA-SORE was critical for maintaining sorafenib resistance
11:37 7.
CircRNA-SORE was critical for maintaining sorafenib resistance
14:21 8.
CircRNA-SORE was critical for maintaining sorafenib resistance
16:45 9.
CircRNA-SORE was critical for maintaining sorafenib resistance
18:07 10.
CircRNA-SORE functioned by binding to YBX1 protein
18:12 11.
CircRNA-SORE was critical for maintaining sorafenib resistance
18:24 12.
CircRNA-SORE functioned by binding to YBX1 protein
23:17 13.
CircRNA-SORE functioned by binding to YBX1 protein
27:53 14.
CircRNA-SORE functioned by binding to YBX1 protein
30:39 15.
CircRNA-SORE functioned by binding to YBX1 protein
32:43 16.
CircRNA-SORE functioned by binding to YBX1 protein
33:15 17.
CircRNA-SORE functioned by binding to YBX1 protein
33:19 18.
CircRNA-SORE functioned by binding to YBX1 protein
33:56 19.
Patients with lower circRNA-SORE or YBX1 expression were associated with better recurrence-free survival
42:44 20.
CircRNA-SORE stabilized YBX1 by preventing its PRP19-mediated degradation
47:08 21.
CircRNA-SORE stabilized YBX1 by preventing its PRP19-mediated degradation
47:58 22.
CircRNA-SORE stabilized YBX1 by preventing its PRP19-mediated degradation
50:41 23.
CircRNA-SORE stabilized YBX1 by preventing its PRP19-mediated degradation
51:56 24.
CircRNA-SORE stabilized YBX1 by preventing its PRP19-mediated degradation
54:44 25.
CircRNA-SORE transmited sorafenib resistance by exosomes
59:13 26.
CircRNA-SORE transmited sorafenib resistance by exosomes
1:05:11 27.
Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
1:05:26 28.
CircRNA-SORE transmited sorafenib resistance by exosomes
1:05:28 29.
** after 20221121.pptx
1:05:48 30.
CircRNA-SORE transmited sorafenib resistance by exosomes
1:06:19 31.
Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
1:06:21 32.
** after 20221121.pptx
1:06:25 33.
Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
1:08:31 34.
Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
1:08:46 35.
Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
1:09:22 36.
Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
1:09:30 37.
Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
1:09:33 38.
Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
1:09:39 39.
Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
1:12:00 40.
Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
1:12:10 41.
Conclusion
1:16:53 42.
** after 20221121.pptx

分享
- 嵌入網址
- QR code

索引
筆記
討論
全螢幕

20221121_lab meeting_怡君

長度: 1:16:56, 瀏覽: 498, 最近修訂: 2022-11-21

20221121.pptx

附件:

20221121.pptx (6.9 MB)

00:00 1.
index 1
01:28 2.
CircRNA-SORE was overexpressed in sorafenib-resistant HCC cells
05:10 3.
CircRNA-SORE was overexpressed in sorafenib-resistant HCC cells
05:18 4.
CircRNA-SORE was overexpressed in sorafenib-resistant HCC cells
07:09 5.
CircRNA-SORE was overexpressed in sorafenib-resistant HCC cells
11:04 6.
CircRNA-SORE was critical for maintaining sorafenib resistance
11:37 7.
CircRNA-SORE was critical for maintaining sorafenib resistance
14:21 8.
CircRNA-SORE was critical for maintaining sorafenib resistance
16:45 9.
CircRNA-SORE was critical for maintaining sorafenib resistance
18:07 10.
CircRNA-SORE functioned by binding to YBX1 protein
18:12 11.
CircRNA-SORE was critical for maintaining sorafenib resistance
18:24 12.
CircRNA-SORE functioned by binding to YBX1 protein
23:17 13.
CircRNA-SORE functioned by binding to YBX1 protein
27:53 14.
CircRNA-SORE functioned by binding to YBX1 protein
30:39 15.
CircRNA-SORE functioned by binding to YBX1 protein
32:43 16.
CircRNA-SORE functioned by binding to YBX1 protein
33:15 17.
CircRNA-SORE functioned by binding to YBX1 protein
33:19 18.
CircRNA-SORE functioned by binding to YBX1 protein
33:56 19.
Patients with lower circRNA-SORE or YBX1 expression were associated with better recurrence-free survival
42:44 20.
CircRNA-SORE stabilized YBX1 by preventing its PRP19-mediated degradation
47:08 21.
CircRNA-SORE stabilized YBX1 by preventing its PRP19-mediated degradation
47:58 22.
CircRNA-SORE stabilized YBX1 by preventing its PRP19-mediated degradation
50:41 23.
CircRNA-SORE stabilized YBX1 by preventing its PRP19-mediated degradation
51:56 24.
CircRNA-SORE stabilized YBX1 by preventing its PRP19-mediated degradation
54:44 25.
CircRNA-SORE transmited sorafenib resistance by exosomes
59:13 26.
CircRNA-SORE transmited sorafenib resistance by exosomes
1:05:11 27.
Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
1:05:26 28.
CircRNA-SORE transmited sorafenib resistance by exosomes
1:05:28 29.
** after 20221121.pptx
1:05:48 30.
CircRNA-SORE transmited sorafenib resistance by exosomes
1:06:19 31.
Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
1:06:21 32.
** after 20221121.pptx
1:06:25 33.
Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
1:08:31 34.
Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
1:08:46 35.
Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
1:09:22 36.
Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
1:09:30 37.
Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
1:09:33 38.
Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
1:09:39 39.
Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
1:12:00 40.
Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
1:12:10 41.
Conclusion
1:16:53 42.
** after 20221121.pptx

位置

資料夾名稱

2022

發表人

林俐妤

單位

賴亮全教授

建立

2022-11-21 10:48:23

最近修訂

2022-11-21 11:11:55

長度

1:16:56